| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Jun 24, 2024 | Rock Edwin Chief Medical Officer | Buy | Glycomimetics Inc | GLYC | $0.26 | $78,825 | +30.95% |
| Sep 21, 2023 | Sep 25, 2023 | Rock Edwin Chief Medical Officer | Buy | Glycomimetics Inc | GLYC | $1.38 | $90,256 | +14.84% |
| Dec 22, 2022 | Dec 27, 2022 | Rock Edwin Chief Medical Officer | Buy | Glycomimetics Inc | GLYC | $2.25 | $247,500 | +26.19% |
| Nov 14, 2022 | Nov 16, 2022 | Rock Edwin Chief Medical Officer | Buy | Glycomimetics Inc | GLYC | $1.55 | $309,000 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.